Literature DB >> 26677947

HIV-1 Transgenic Rat Prefrontal Cortex Hyper-Excitability is Enhanced by Cocaine Self-Administration.

Wesley N Wayman1,2, Lihua Chen1,2, Xiu-Ti Hu1,2, T Celeste Napier1,2,3.   

Abstract

The medial prefrontal cortex (mPFC) is dysregulated in HIV-1-infected humans and the dysregulation is enhanced by cocaine abuse. Understanding mPFC pathophysiology in this comorbid state has been hampered by the dearth of relevant animal models. To help fill this knowledge gap, electrophysiological assessments were made of mPFC pyramidal neurons (PN) from adult male HIV-1 transgenic (Tg) F344 rats (which express seven of the nine HIV-1 toxic proteins) and non-Tg F344 rats that self-administered cocaine for 14 days (COC-SA), as well as saline-yoked controls (SAL-Yoked) and experimentally naive Tg and non-Tg rats. Forebrain slices were harvested and prepared for whole-cell patch-clamp recording, and in treated rats, this occurred after 14-18 days of forced abstinence. Aged-matched rats were used for immunohistochemical detection of the L-channel protein, Cav1.2-α1c. We determined that: (i) the two genotypes acquired the operant task and maintained similar levels of COC-SA, (ii) forced abstinence from COC-SA enhanced mPFC PN excitability in both genotypes, and neurons from Tg rats exhibited the greatest pathophysiology, (iii) neurons from SAL-Yoked Tg rats were more excitable than those from SAL-Yoked non-Tg rats, and in Tg rats (iv) blockade of L-type Ca(2+) channels reduced the enhanced excitability, and (v) Cav1.2-immunoreactivity was increased. These findings provide the first assessment of the mPFC pathophysiology in a rodent model of HIV-1-mediated neuropathology with and without cocaine self-administration. Outcomes reveal an enhanced cortical excitability during chronic exposure to HIV-1 proteins that is excessively exacerbated with cocaine abuse. Such neuropathophysiology may underlie the cognitive dysregulation reported for comorbid humans.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26677947      PMCID: PMC4908633          DOI: 10.1038/npp.2015.366

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  38 in total

Review 1.  Channels underlying neuronal calcium-activated potassium currents.

Authors:  Pankaj Sah; E S Louise Faber
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

2.  Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.

Authors:  T Celeste Napier; Lihua Chen; Fatah Kashanchi; Xiu-Ti Hu
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-25       Impact factor: 4.147

3.  Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.

Authors:  Scot McIntosh; Tammy Sexton; Lindsey P Pattison; Steven R Childers; Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-10       Impact factor: 4.147

4.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.

Authors:  W Reid; M Sadowska; F Denaro; S Rao; J Foulke; N Hayes; O Jones; D Doodnauth; H Davis; A Sill; P O'Driscoll; D Huso; T Fouts; G Lewis; M Hill; R Kamin-Lewis; C Wei; P Ray; R C Gallo; M Reitz; J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

5.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

Review 6.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

7.  Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Authors:  Valerio Tozzi; Pietro Balestra; Rita Bellagamba; Angela Corpolongo; Maria Flora Salvatori; Ubaldo Visco-Comandini; Chrysoula Vlassi; Marinella Giulianelli; Simonetta Galgani; Andrea Antinori; Pasquale Narciso
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

8.  Intrinsic excitability of CA1 pyramidal neurones from the rat dorsal and ventral hippocampus.

Authors:  Kelly A Dougherty; Tasnim Islam; Daniel Johnston
Journal:  J Physiol       Date:  2012-09-17       Impact factor: 5.182

9.  Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement.

Authors:  M Jones; K Olafson; M R Del Bigio; J Peeling; A Nath
Journal:  J Neuropathol Exp Neurol       Date:  1998-06       Impact factor: 3.685

Review 10.  Plasticity in the prefrontal cortex of adult rats.

Authors:  Bryan Kolb; Robbin Gibb
Journal:  Front Cell Neurosci       Date:  2015-02-03       Impact factor: 5.505

View more
  25 in total

Review 1.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

2.  Male HIV-1 transgenic rats show reduced cocaine-maintained lever-pressing compared to F344 wildtype rats despite similar baseline locomotion.

Authors:  Y Wendy Huynh; Brady M Thompson; Christopher E Larsen; Shilpa Buch; Ming-Lei Guo; Rick A Bevins; Jennifer E Murray
Journal:  J Exp Anal Behav       Date:  2020-02-20       Impact factor: 2.468

3.  Impact on Cortical Function of Cocaine Abuse Co-Occurring with HIV.

Authors:  T Celeste Napier
Journal:  Neuropsychopharmacology       Date:  2017-01       Impact factor: 7.853

4.  COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV.

Authors:  Rowan Saloner; Maria J Marquine; Erin E Sundermann; Suzi Hong; John Allen McCutchan; Ronald J Ellis; Robert K Heaton; Igor Grant; Mariana Cherner
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

5.  HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens.

Authors:  G Cristina Brailoiu; Elena Deliu; Jeffrey L Barr; Linda M Console-Bram; Alexandra M Ciuciu; Mary E Abood; Ellen M Unterwald; Eugen Brailoiu
Journal:  Drug Alcohol Depend       Date:  2017-06-08       Impact factor: 4.492

6.  Combined chronic blockade of hyper-active L-type calcium channels and NMDA receptors ameliorates HIV-1 associated hyper-excitability of mPFC pyramidal neurons.

Authors:  Christina E Khodr; Lihua Chen; Sonya Dave; Lena Al-Harthi; Xiu-Ti Hu
Journal:  Neurobiol Dis       Date:  2016-06-17       Impact factor: 5.996

7.  Enhanced neuronal and blunted hemodynamic reactivity to cocaine in the prefrontal cortex following extended cocaine access: optical imaging study in anesthetized rats.

Authors:  Craig P Allen; Kicheon Park; Ang Li; Nora D Volkow; George F Koob; Yingtian Pan; Xiu-Ti Hu; Congwu Du
Journal:  Addict Biol       Date:  2018-03-05       Impact factor: 4.280

8.  Aging alters voltage-gated calcium channels in prefrontal cortex pyramidal neurons in the HIV brain.

Authors:  Christina E Khodr; Lihua Chen; Lena Al-Harthi; Xiu-Ti Hu
Journal:  J Neurovirol       Date:  2017-10-31       Impact factor: 2.643

Review 9.  Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.

Authors:  Bradley Nash; Lindsay Festa; Chihyang Lin; Olimpia Meucci
Journal:  Brain Res       Date:  2019-08-26       Impact factor: 3.252

10.  Overlapping Risky Decision-Making and Olfactory Processing Ability in HIV-Infected Individuals.

Authors:  Christopher Jackson; Narayan Rai; Charlee K McLean; Maria Mananita S Hipolito; Flora Terrell Hamilton; Suad Kapetanovic; Evaristus A Nwulia
Journal:  Clin Exp Psychol       Date:  2017-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.